These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
423 related articles for article (PubMed ID: 19958626)
21. Definitive irradiation in multidisciplinary management of localized Ewing sarcoma family of tumors in pediatric patients: outcome and prognostic factors. Krasin MJ; Rodriguez-Galindo C; Billups CA; Davidoff AM; Neel MD; Merchant TE; Kun LE Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):830-8. PubMed ID: 15465200 [TBL] [Abstract][Full Text] [Related]
22. Ewing's sarcoma: only patients with 100% of necrosis after chemotherapy should be classified as having a good response. Albergo JI; Gaston CL; Laitinen M; Darbyshire A; Jeys LM; Sumathi V; Parry M; Peake D; Carter SR; Tillman R; Abudu AT; Grimer RJ Bone Joint J; 2016 Aug; 98-B(8):1138-44. PubMed ID: 27482030 [TBL] [Abstract][Full Text] [Related]
23. Radiation therapy for Ewing's sarcoma: results from Memorial Sloan-Kettering in the modern era. La TH; Meyers PA; Wexler LH; Alektiar KM; Healey JH; Laquaglia MP; Boland PJ; Wolden SL Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):544-50. PubMed ID: 16198063 [TBL] [Abstract][Full Text] [Related]
24. Prognostic factors in patients with localized Ewing's sarcoma: the effect on survival of actual received drug dose intensity and of histologic response to induction therapy. Delepine N; Delepine G; Cornille H; Voisin MC; Brun B; Desbois JC J Chemother; 1997 Oct; 9(5):352-63. PubMed ID: 9373791 [TBL] [Abstract][Full Text] [Related]
25. Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide--a Children's Cancer Group and Pediatric Oncology Group study. Miser JS; Krailo MD; Tarbell NJ; Link MP; Fryer CJ; Pritchard DJ; Gebhardt MC; Dickman PS; Perlman EJ; Meyers PA; Donaldson SS; Moore S; Rausen AR; Vietti TJ; Grier HE J Clin Oncol; 2004 Jul; 22(14):2873-6. PubMed ID: 15254055 [TBL] [Abstract][Full Text] [Related]
26. Five-year results in Ewing's sarcoma. The Scandinavian Sarcoma Group experience with the SSG IX protocol. Elomaa I; Blomqvist CP; Saeter G; Akerman M; Stenwig E; Wiebe T; Björk O; Alvegård TA Eur J Cancer; 2000 May; 36(7):875-80. PubMed ID: 10785592 [TBL] [Abstract][Full Text] [Related]
27. Long-term results from the first UKCCSG Ewing's Tumour Study (ET-1). United Kingdom Children's Cancer Study Group (UKCCSG) and the Medical Research Council Bone Sarcoma Working Party. Craft AW; Cotterill SJ; Bullimore JA; Pearson D Eur J Cancer; 1997 Jun; 33(7):1061-9. PubMed ID: 9376188 [TBL] [Abstract][Full Text] [Related]
28. Ifosfamide-containing chemotherapy in Ewing's sarcoma: The Second United Kingdom Children's Cancer Study Group and the Medical Research Council Ewing's Tumor Study. Craft A; Cotterill S; Malcolm A; Spooner D; Grimer R; Souhami R; Imeson J; Lewis I J Clin Oncol; 1998 Nov; 16(11):3628-33. PubMed ID: 9817284 [TBL] [Abstract][Full Text] [Related]
29. Neoadjuvant chemotherapy for Ewing's sarcoma of bone: no benefit observed after adding ifosfamide and etoposide to vincristine, actinomycin, cyclophosphamide, and doxorubicin in the maintenance phase--results of two sequential studies. Bacci G; Picci P; Ferrari S; Mercuri M; Brach del Prever A; Rosito P; Barbieri E; Tienghi A; Forni C Cancer; 1998 Mar; 82(6):1174-83. PubMed ID: 9506366 [TBL] [Abstract][Full Text] [Related]
30. Non-metastatic Ewing's sarcoma family of tumors of bone in adolescents and adults: prognostic factors and clinical outcome-single institution results. Oksüz DC; Tural D; Dincbas FÖ; Dervisoglu S; Turna H; Hiz M; Kantarci F; Ceylaner B; Koca S; Mandel NM Tumori; 2014; 100(4):452-8. PubMed ID: 25296596 [TBL] [Abstract][Full Text] [Related]
36. Clinical outcome of patients with recurrent or refractory localized Ewing's sarcoma family of tumors: A retrospective report from the Japan Ewing Sarcoma Study Group. Umeda K; Miyamura T; Yamada K; Sano H; Hosono A; Sumi M; Okita H; Kumamoto T; Kawai A; Hirayama J; Jyoko R; Sawada A; Nakayama H; Hosoya Y; Maeda N; Yamamoto N; Imai C; Hasegawa D; Chin M; Ozaki T; Cancer Rep (Hoboken); 2021 Jun; 4(3):e1329. PubMed ID: 33452866 [TBL] [Abstract][Full Text] [Related]
37. Ewing's sarcoma of the ribs. A report from the cooperative Ewing's sarcoma study. Ozaki T; Lindner N; Hoffmann C; Hillmann A; Rödl R; Blasius S; Link T; Winkelmann W; Jürgens H Eur J Cancer; 1995 Dec; 31A(13-14):2284-8. PubMed ID: 8652257 [TBL] [Abstract][Full Text] [Related]
38. High-dose chemotherapy followed by autologous stem cell transplantation for adult patients With first relapse of Ewing's sarcoma: A single institution experience. Paksoy N; Ferhatoglu F; Dogan İ; Khanmammadov N; Iribas Celik A; Gulbas Z; Başaran M Medicine (Baltimore); 2022 Dec; 101(49):e32213. PubMed ID: 36626465 [TBL] [Abstract][Full Text] [Related]
39. Results of RS-99 protocol for childhood solid tumors. Cai JY; Tang JY; Pan C; Xu M; Xue HL; Zhou M; Dong L; Ye QD; Jiang H; Shen SH; Chen J World J Pediatr; 2010 Feb; 6(1):43-9. PubMed ID: 20143210 [TBL] [Abstract][Full Text] [Related]
40. Impact of chemotherapy cycles and intervals on outcomes of nonspinal Ewing sarcoma in adults: a real-world experience. Zhang J; Huang Y; Sun Y; He A; Zhou Y; Hu H; Yao Y; Shen Z BMC Cancer; 2019 Dec; 19(1):1168. PubMed ID: 31791278 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]